Subscribe to Newsletter
Subspecialties Oncology, Hematology, Screening and monitoring

Two Perspectives: Patient and Hematopathologist Discussion on Importance of CML Monitoring

sponsored by Cepheid

View On-Demand

May 24th, 2022 - 10 am PST

Patients diagnosed with CML 20 years ago could live for around five years. Today CML patients can live everyday life on medication. With patients living longer with this disease, routine CML monitoring is critical to ensure a continued response to treatment.

CML Patients can have an everyday life with a fast and accurate CML Monitoring solution

Cepheid Solution for CML Monitoring (rapid and accurate) at the lab - Xpert® BCR-ABL Ultra

In this webinar, 27-year terminally diagnosed CML survivor Mel Mann, M.B.A., M.Ed, and Dr. Guang Fan, MD, Ph.D., Director of Hematopathology Program at Oregon Health & Science University, will talk about the importance of routine CML Monitoring and the benefits of getting same-day results.

Webinar Learning Objectives:

  • CML Patient can have a normal life with rapid and fast CML Monitoring solution - BCR ABL ULTRA
  • Cepheid Solution for CML Monitoring (rapid and accurate) at the lab - BCR ABL ULTRA

View On-Demand

Visit our Webinar Hub

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Related Application Notes
Tumor Genomic Profiling with SureSelect Cancer Tumor-Specific Assays

| Contributed by Agilent

Comprehensive Genomic Profiling with SureSelect Cancer CGP Assay

| Contributed by Agilent

Preventing Bias in scRNAseq Performed on Solid Tumors

| Contributed by Revvity

Related Product Profile
Diagnostics Genetics and epigenetics
QIAseq® Pan Cancer Multimodal cuts user interventions by 50%

| Contributed by QIAGEN

Most Popular
Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine